MB-07803 is a FBPase inhibitor potentially for the treatment of type 2 diabetes. References: van Poelje PD, Potter SC, Erion MD. Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes. Handb Exp Pharmacol. 2011;(203):279-301. doi: 10.1007/978-3-642-17214-4_12. Review. PubMed PMID: 21484576.

纯度：≥98%

CAS：882757-24-6